Impact of 'LH activity' supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review

被引:19
作者
Hugues, J. N. [1 ]
机构
[1] Univ Paris 13, Jean Verdier Hosp, Reprod Med Unit, F-93143 Bondy, France
关键词
progesterone; LH activity; controlled ovarian stimulation; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LATE FOLLICULAR PHASE; HIGHLY PURIFIED HMG; LUTEINIZING-HORMONE; RECOMBINANT FSH; PREMATURE LUTEINIZATION; GNRH ANTAGONISTS; PREGNANCY RATES;
D O I
10.1093/humrep/der380
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The influence of LH on serum progesterone rise during gonadotrophin stimulation is a matter of debate. The purpose of this analysis was to assess the impact of supplementation with 'LH activity' products on serum progesterone changes before hCG administration in GnRH analog-treated women. METHODS: A computerized literature search was performed to identify studies comparing FSH treatment alone to those that provided supplementation with 'LH activity' using hMG, recombinant (r)LH (rLH) or hCG in GnRH analog protocols. Data regarding stimulation regimens were extracted from those that reported serum progesterone levels at the time of hCG in order to assess the specific role of LH activity products. RESULTS: Serum progesterone determination at the time of hCG administration was performed in 34 out of 108 studies comparing the effects of FSH alone or in combination with LH activity products. In a vast majority, no significant difference in serum progesterone could be found between stimulation regimens. However, in four studies where LH activity (three hMG and one rLH) was administered from the beginning of ovarian stimulation, serum P-values were significantly decreased. In contrast, in two studies where LH activity (hCG) was provided during the late follicular phase, serum P-values were significantly increased. Analysis of confounding factors showed that the intensity of ovarian stimulation is the most important determining factor to explain serum progesterone elevation at the time of hCG administration, CONCLUSIONS: This systematic review shows that providing LH activity supplementation in combination with FSH during ovarian stimulation does not have a consistent effect on serum progesterone concentrations at the time of hCG administration. However, these data also suggest that, in accordance with physiological concept, the timing of LH activity administration could influence the impact on serum progesterone changes.
引用
收藏
页码:232 / 243
页数:12
相关论文
共 64 条
[1]   Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone [J].
Adonakis, G ;
Deshpande, N ;
Yates, RWS ;
Fleming, R .
FERTILITY AND STERILITY, 1998, 69 (03) :450-453
[2]   Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial [J].
Andersen, Anders Nyboe ;
Devroey, Paul ;
Arce, Joan-Carles .
HUMAN REPRODUCTION, 2006, 21 (12) :3217-3227
[3]   Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate [J].
Andersen, Claus Yding ;
Bungum, Leif ;
Andersen, Anders Nyboe ;
Humaidan, Peter .
REPRODUCTIVE BIOMEDICINE ONLINE, 2011, 23 (02) :187-195
[4]  
Balasch Juan, 2003, Reprod Biomed Online, V7, P35
[5]  
BENTICK B, 1988, FERTIL STERIL, V50, P79
[6]   Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study [J].
Blockeel, C. ;
De Vos, M. ;
Verpoest, W. ;
Stoop, D. ;
Haentjens, P. ;
Devroey, P. .
HUMAN REPRODUCTION, 2009, 24 (11) :2910-2916
[7]   Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study [J].
Bosch, E. ;
Vidal, C. ;
Labarta, E. ;
Simon, C. ;
Remohi, J. ;
Pellicer, A. .
HUMAN REPRODUCTION, 2008, 23 (10) :2346-2351
[8]   Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome [J].
Bosch, E ;
Escudero, E ;
Crespo, J ;
Simón, C ;
Remohí, J ;
Pellicer, A .
FERTILITY AND STERILITY, 2005, 84 (05) :1529-1532
[9]   Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome [J].
Bosch, E ;
Valencia, W ;
Escudero, E ;
Crespo, J ;
Simón, C ;
Remohi, J ;
Pellicer, A .
FERTILITY AND STERILITY, 2003, 80 (06) :1444-1449
[10]   Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles [J].
Bosch, E. ;
Labarta, E. ;
Crespo, J. ;
Simon, C. ;
Remohi, J. ;
Jenkins, J. ;
Pellicer, A. .
HUMAN REPRODUCTION, 2010, 25 (08) :2092-2100